Healthcare News and Research

Latest Healthcare News and Research

Kaiser denies Prime Healthcare claims over purchase of Daughters of Charity Health System

In a bizarre announcement, Prime Healthcare said Monday that Kaiser Permanente was now supporting its purchase of Daughters of Charity Health System, a claim that Kaiser has unequivocally denied.

11 Feb 2015

Teddy leg bags set to make life more bearable for young children

The child-friendly bags, developed by the National Institute for Health Research’s (NIHR) Devices for Dignity Healthcare Technology Co-operative offer a far less unpleasant experience for young children and are imprinted with Mummy and Baby bear images.

10 Feb 2015

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex's biosimilar candidate to Genentech's LUCENTIS (ranibizumab injection).

10 Feb 2015

eClinicalHealth announces approval of Europe's first remote clinical study in patients with diabetes

eClinicalHealth Limited, a technology and consulting company dedicated to providing innovative clinical trial solutions, is proud to announce the Ethical Committee approval of VERKKO in Finland - Europe's first remote clinical study to include full electronic informed consent.

10 Feb 2015

AirStrip, Batswadi announce strategic partnership to bring AirStrip products into Africa

AirStrip and The Batswadi Group have announced a strategic partnership to bring the AirStrip ONE mobile interoperability platform and the Sense4Baby wireless fetal/maternal monitoring system into ten African countries, with an initial launch in South Africa.

10 Feb 2015

Synthetic Biologics reports positive results from SYN-004 Phase 1b trial to prevent C. difficile infection

Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.

10 Feb 2015

Excluding cancer survivors from lung cancer clinical trials may not be justified, study finds

The common practice of excluding patients with a prior cancer diagnosis from lung cancer clinical trials may not be justified, according to a study by researchers from UT Southwestern Medical Center.

10 Feb 2015

Ten hospital programs recognized for improving health of local communities

From street outreach in Burlington, Vermont to a New York City taxi network to infant mortality prevention in Detroit, ten hospital programs were named Programs of Excellence for their achievements in improving the health of local communities. Each program was awarded $10,000 through the Hospital Charitable Services Awards, a national program sponsored by Jackson Healthcare.

10 Feb 2015

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.

10 Feb 2015

Chiasma announces publication of octreotide capsules Phase III study results in JCEM

Chiasma Inc., a U.S. privately-held biopharma company, announced today that results from a multicenter Phase III study of the investigational new drug, octreotide capsules, were published online for early release on Feb. 9, ahead of print, by the Journal of Clinical Endocrinology & Metabolism.

10 Feb 2015

HPV vaccine does not increase rates of STIs in adolescent females

Receiving the human papillomavirus vaccine does not increase rates of sexually transmitted infections (STIs) in adolescent females. The vaccine, which can prevent cervical cancer in women, has had a low uptake, partly because of concerns about how it will affect adolescent sexual activity.

10 Feb 2015

New analysis takes comprehensive look at how patients feel about doctors' attire

What should doctors wear? And how does something as simple as their choice of a suit, scrubs or slacks influence how patients view them?

10 Feb 2015

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA gene-patent litigation.

From Quest Diagnostics 10 Feb 2015

Velano Vascular announces FDA approval of new blood-draw technology

Velano Vascular today announced that the U.S. Food and Drug Administration has granted marketing clearance for a new technology that provides an innovative approach to one of the most common procedures in medicine – the in-hospital blood draw.

10 Feb 2015

Biocartis to develop Rapid Ebola Virus Triage Test

Biocartis believes its Rapid Ebola Virus Triage Test could provide a sustainable solution for rapid detection of Ebola-infected patients even after the current Ebola outbreak.

From Biocartis 10 Feb 2015

Roche announces acquisition of Signature Diagnostics

Roche announced today the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical studies.

From Roche Sequencing and Life Science 10 Feb 2015

Intensive behavioral intervention can help eliminate pica in autistic children

Intensive behavioral intervention can be effective at eliminating pica, which is the repeated ingestion of inedible substances, researchers from Marcus Autism Center report.

10 Feb 2015

New study reveals eight highly specific physical signs associated with death in cancer patients

While the diagnosis of an impending death is always sad, it can be important for patients, families, and clinicians as they make decisions related to hospital discharge, hospice referral, and treatments. Now a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, has revealed eight highly specific physical signs associated with death within three days in cancer patients.

10 Feb 2015

TeamHealth partners with St. David's HealthCare to expand services to greater Austin, Texas market

TeamHealth Holdings Inc., one of the nation's largest providers of outsourced physician staffing solutions for hospitals, announced today it will expand services to the greater Austin, Texas market through a strategic partnership with St. David's HealthCare, a six-hospital system.

10 Feb 2015

BPC opens new plasma collection center in Jacksonville, North Carolina

Biotest Pharmaceuticals Corporation, a leading developer of immunology biotherapeutic products, is pleased to announce that it has opened a new plasma collection center. The state-of-the-art, 15,000 square foot facility located at 113 Yopp Road, Jacksonville, North Carolina, is BPC's second plasma center in Jacksonville, and officially opened its doors for business on February 3, 2015.

9 Feb 2015

Healthcare News and Research

Latest Healthcare News and Research

Kaiser denies Prime Healthcare claims over purchase of Daughters of Charity Health System

Teddy leg bags set to make life more bearable for young children

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

eClinicalHealth announces approval of Europe's first remote clinical study in patients with diabetes

AirStrip, Batswadi announce strategic partnership to bring AirStrip products into Africa

Synthetic Biologics reports positive results from SYN-004 Phase 1b trial to prevent C. difficile infection

Excluding cancer survivors from lung cancer clinical trials may not be justified, study finds

Ten hospital programs recognized for improving health of local communities

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

Chiasma announces publication of octreotide capsules Phase III study results in JCEM

HPV vaccine does not increase rates of STIs in adolescent females

New analysis takes comprehensive look at how patients feel about doctors' attire

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Velano Vascular announces FDA approval of new blood-draw technology

Biocartis to develop Rapid Ebola Virus Triage Test

Roche announces acquisition of Signature Diagnostics

Intensive behavioral intervention can help eliminate pica in autistic children

New study reveals eight highly specific physical signs associated with death in cancer patients

TeamHealth partners with St. David's HealthCare to expand services to greater Austin, Texas market

BPC opens new plasma collection center in Jacksonville, North Carolina

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in